| Followers | 12 |
| Posts | 1963 |
| Boards Moderated | 0 |
| Alias Born | 04/16/2024 |
Friday, December 06, 2024 11:24:28 AM
Recent TELO News
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 02/19/2026 10:16:10 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/19/2026 10:12:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 01:00:48 PM
- Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models • ACCESS Newswire • 02/17/2026 01:00:00 PM
- Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging • ACCESS Newswire • 02/05/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 12:30:43 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 01/23/2026 10:04:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 01:00:54 PM
- Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models • ACCESS Newswire • 01/05/2026 01:00:00 PM
- Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development • ACCESS Newswire • 12/18/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2025 09:01:45 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 11/28/2025 09:59:00 PM
- Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells • ACCESS Newswire • 11/25/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2025 09:01:40 PM
- Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells • ACCESS Newswire • 11/21/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 10:15:27 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 11/20/2025 09:16:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:01:58 PM
- Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line • ACCESS Newswire • 11/12/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:00:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/10/2025 09:01:41 PM
- Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer's “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo • ACCESS Newswire • 10/23/2025 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2025 08:01:35 PM
- Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth • ACCESS Newswire • 10/21/2025 11:30:00 AM
- Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer • ACCESS Newswire • 10/14/2025 12:00:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
